CG Oncology, Inc. Common stock
CG Oncology, Inc. Common stock (CGON) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
cgon · stock forecast · 10 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 10 Wall Street analysts in the past 3 months
Buy
10 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$93.00
Consensus
$82.57
+53.7% upside
Low
$70.00
Median: $82 · Last Close: $53.72
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$82.57
53.7% upside
High Target
$93
73.1%
Low Target
$70
30.3%
Current Price
$53.72
as of today
Based on analyst price targets, the CGON stock price prediction for the next 12 months ranges from $70 to $93. The consensus CGON price forecast of $82.57 implies 53.7% upside from the current price of $53.72.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $51.03 | ↓ 5.00% |
1-day model range: $50.75–$51.32. Peak: $51.32 (-5.00%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $56 | +5.0% |
| 2028 | $58 | +8.2% |
| 2029 | $59 | +10.2% |
| 2030 | $60 | +11.4% |
| 2031 | — | +12.1% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CGON · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-18 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-14 | Truist Securities | Maintains | Buy→Buy |
| 2026-05-11 | JP Morgan | Maintains | Overweight→Overweight |
| 2026-05-11 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-05-11 | Truist Securities | Maintains | Buy→Buy |
| 2026-05-11 | Wedbush | Maintains | Outperform→Outperform |
| 2026-04-27 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-04-17 | JP Morgan | Maintains | Overweight→Overweight |
| 2026-04-07 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-27 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on CG Oncology, Inc. Common stock (CGON) stock. Of the recent 45 rating actions, 2 were upgrades and 0 were downgrades. 10 analysts currently cover CGON.
Analyst Recommendation Trends
CGON analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 6 to 6 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$11M
↓ 97.6% YoY
Revenue Next Year
$87M
↑ 689.4% YoY
EPS This Year
$-2.74
EPS Next Year
$-2.84
↑ 3.4% YoY
EPS ForecastReported vs Estimated
Analysts forecast CGON EPS of $-2.74 for the current fiscal year, based on estimates from 12 analysts. The CGON revenue forecast is $11M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The CGON stock forecast is supported by two independent data sources: analyst consensus ratings from 10 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus CGON price target is $82.57 (+53.7% upside), with an analyst consensus of Buy.
The CGON short-term stock prediction for tomorrow is $51.03 (-5.00%). The CGON stock price prediction for 2027 estimates an average of $56. The CGON stock prediction for 2030 projects a range of $56–$63.
CG Oncology, Inc. Common stock trades on NASDAQ under the ticker CGON. The CGON stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
CGON forecast · 8 questionsAccording to 10 Wall Street analysts, the average 12-month CGON price target is $82.57, with a high forecast of $93.00 and a low of $70.00. The median price target is shown in the chart above when available. This implies +53.7% potential upside from the current price of $53.72.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.